Accelerate access to clinical phases
PhinC Development is the expert partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research.
Thanks to a multidisciplinary team with thorough field experience, PhinC helps to take the best decisions concerning drug development using all existing pharmacology and pharmacometrics modeling & simulation (M&S) tools.
Our experts in clinical development
Four experts in clinical development with more than 20 years of experience - Bernard Orlandini, Eric Evène, Virginie Gualano and Mathieu Felices - cofounded PhinC Development in 2008.
PhinC Development has highly qualified experts in clinical pharmacology, pharmacokinetics, and biostatistics in a wide range of therapeutic areas. All members of the team have a deep knowledge in drug development and bring their expertise to develop useful and creative PopPK, PBPK and PK/PD models.
They also master the internationally recognized software packages as NONMEM®, SAS®, WinnonLin®, Monolix® and GastroPlus®.
Since the creation of PhinC, the founders have wanted to develop scientific operations around an agile and expert team, but at the same time, meeting the best standards of the pharmaceutical industry, relying in particular on highly qualified resources in the fields of quality assurance, legal, financial, HSE, marketing and communication.
PhinC currently has 16 employees, including 12 operational staff. Our pharmacometricians all have a postgraduate degree in pharmacology, pharmacokinetics, biostatistics and are pharmacists, doctors or research engineers.